Select a language below:

Findings on high-flow nasal cannula in COPD at home

In this symposium, Dr Ulla Møller Weinreich outlines study results into the use of high-flow nasal cannula (HFNC) in COPD at home and what may be in store for the future.
This is a secured video. To access it for the first time you must fill-in your email address above.

Key facts

  • JIVD CONGRESS 2022
  • WITH DR ULLA MØLLER WEINREICH
  • HFT TODAY: NEW CLINICAL RESEARCH AND PRACTICE

Content

During this symposium, Dr. Ulla Weinreich, an expert in the field of high-flow therapy and COPD from the Pulmonary Research Center in Aalborg University, Denmark, outlines the findings on the use of high-flow nasal cannula (HFNC) in COPD at home.

Her findings include information regarding patients’ experiences and feedback, potential reasons for dropouts from HFNC, and insights from the field on the use and follow-up of the therapy at home.

After giving a brief introduction on the interesting history of high-flow respiratory therapy systems, Dr. Weinreich goes on to describe the current benefits of the use of HFNC in hospitals found through more recent research and studies.1-5

Dr. Weinreich’s research delves deeper into the data regarding the long-term effects of oxygen-enriched high-flow nasal cannula in COPD patients with chronic hypoxemic respiratory failure, citing several promising sets of data.6

With so much positive data, Dr. Weinreich and her team made a national recommendation for the home use of high-flow. To learn more about it, register now and watch the full symposium.

Speakers

Dr. Ulla Møller Weinreich

Aalborg University Hospital, Denmark

Looking for more information about high-flow treatment for COPD patients?

Research in home high-flow therapy for COPD

Discover key findings from recent clinical research on the mechanisms of action of home high-flow therapy and the clinical outcomes in patients with COPD.
Learn more

The HiFAE trial

Read more about the new French randomised controlled trial: HiFAE. The main objective of this study is to evaluate the efficacy of home high-flow therapy with oxygen vs standard oxygen therapy for the reduction of acute COPD exacerbations.
Learn more

Home high-flow therapy for COPD

Learn how home high flow therapy could be indicated for domiciliary use in COPD patients experiencing secretion management issues.
Learn more

1. Masclans JR, Roca O. High-flow Oxygen Therapy in Acute Respiratory Failure. Clinical Pulmonary Medicine: May 2012 – Volume 19 – Issue 3 – p 127-130 doi: 10.1097/CPM.0b013e3182514f29

2. Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, Roca J, Barberà JA. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med. 2010 Feb 1;181(3):270-8. doi: 10.1164/rccm.200907-0988OC. Epub 2009 Oct 29. PMID: 19875684.

3. Masclans JR, Pérez-Terán P, Roca O. The role of high flow oxygen therapy in acute respiratory failure. Med Intensiva. 2015;39(8):505-515. doi:10.1016/j.medin.2015.05.009

4. Hui-Bin Huang, Jin-Min Peng, Li Weng, Guang-Yun Liu, Bin Du. High-flow oxygen therapy in immunocompromised patients with acute respiratory failure: A review and meta-analysis. Journal of Critical Care, Volume 43, 2018, Pages 300-305, ISSN 0883-9441, https://doi.org/10.1016/j.jcrc.2017.09.176.

5. Leeies M, Flynn E, Turgeon AF, Paunovic B, Loewen H, Rabbani R, Abou-Setta AM, Ferguson ND, Zarychanski R. High-flow oxygen via nasal cannulae in patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis. Syst Rev. 2017 Oct 16;6(1):202. doi: 10.1186/s13643-017-0593-5. PMID: 29037221; PMCID: PMC5644261.

6. Line Hust Storgaard, Ulla Møller Weinreich & Birgitte Schantz Laursen (2020) COPD Patients’ Experience of Long-Term Domestic Oxygen-Enriched Nasal High Flow Treatment: A Qualitative Study, COPD: Journal of Chronic Obstructive Pulmonary Disease, 17:2, 175-183, DOI: 10.1080/15412555.2020.1736998.